Secondly, RISA is eliminated slowly from the body. Between ~4 and 48 hrs., the most suitable period for brain scanning with this agent, about 50 per cent remains in the blood stream and about 80 per cent in the body. This offers an advantage in detecting richly vascular lesions such as angiomas, malignant gliomas and meningiomas. 6 But, for lesions of low vascularity, the same feature operates to obscure the activity of the target by background radiation.
Neohydrin Labeled with Mercury 2~
Because of these deficiencies Blau and Bender 2 introduced radio-Neohydrin, an organic compound incorporating radioactive mercury 2~ (3-chloromercuri-~-methoxy-propyl-urea). This isotope is characterized by a physical half-life of 45.8 days. A single-line emission of gamma rays eliminates the "foreign" counts coming from the scattered high-energy levels associated with RISA. The lower energy of gamma radiation at ~80 Kev simplifies the problem of shielding. In addition, the more rapid clearance of the radioactive mercurial compound from the body, partly because of its diuretic properties, favours an increase of the target-tobackground ratio, and permits earlier scanning.
The dose of radiation to the whole body from radio-Neohydrin was calculated by Blau and Bender 2 to be about 50 per cent less than that from the amount of RISA commonly employed for brain scanning. One detraction from the value of this agent, however, is the selective dosage of radiation to the kidney. Blau and Bender reported that this can be reduced by a blocking dose of nonradioactive Mercurhydrin which precedes the injection of the radio-Neohydrin.
Other approaches that may decrease the dosage to the kidney include the chemical elimination of free mercury from the Neohydrin preparation and the use of mercury 197 with a shorter half-life of 65 hrs. and absence of beta radiation. (See Addendum.)
Using a single extracranial detector with focusing collimation and a photo-scanning system, Blau and Bender 1,2 compared RISA and radioactive mercury in 100 patients. While the details of the type or verification of the intracranial lesions are not presented, they noted that radiomercury gave more readily interpretable scans in one-quarter to one-third of the cases and "in about 5 to 10 per cent a diagnosis would be made from the Neohydrin scans but not from the albumin scans." Previously, they had found localization about 85 per cent of the time in over 300 cases scanned with RISA. They concluded that radiomercury should raise this figure but noted, "The room for improvement is rather limited. "2 Brinkman and others, 3 using radio-Neohydrin and a scanning system similar to that used by Blau and Bender, reported positive scans in two-thirds of a series of patients with verified intracranial tumours. This compares unfavourably with the rate of detection of 80 per cent or more reported by numerous authors using either RISA or arsenic 74, and also with that reported by Sklaroff and others s who obtained positive scans in 85 per cent of a series of ~0 verified brain tumours using radiomercury.
Comparative Study of RISA and Mercury 2~
While the use of radio-Neohydrin appears to be having an enthusiastic reception for brain scanning, no study has yet been reported in a series of patients with verified lesions to compare the advantages of this agent quantitatively with RISA. Such a study is not done easily with a unilateral photo-scanning system in which exact registration of radioactivity is sacrificed in order to display the most suitable contrast between the local uptake and the background activity on one side of the head.
With the contour scanner, a-6 however, two homologous regions on either side of the head are surveyed simultaneously. Exact rates of count are registered on the final scanning chart, so that a quantitative comparison can be made readily between the differential uptake over the lesion and the background activity of a corresponding normal region of brain on the opposite side of the head. This method also allows a direct comparison of repeated scans on the same patient at different times and with different radioisotopes.
Using this method, we have made double isotopic studies in a selected series of verified tumours. The patients were first scanned using radio-Neohydrin and then with RISA. In each instance repeated scans were carried out as soon as possible after the injection of the agent and were repeated at suitable intervals to give the values of the differential uptake over the lesion as a function of time.
The results indicate clearly that radiomercury 2~ tagged onto Neohydrin gives earlier and higher local uptakes as compared to radioactive iodinated serum albumin.
Method
Patients were given an intramuscular injection of 2 cc. of nonradioactive Mercurhydrin on the day before scanning. Radio-Neohydrin was injected in the dosage of 10 gc. per kg. of body weight. The patients were scanned immediately and again at 3-and 6-hr. intervals. The pulseheight analyser was set to cover a range of gamma radiation between 210 and 380 Key.
Scans with radioactive iodinated serum albumin were made several days later. The injection of 300-400/zc. of RISA was preceded by Lugol's iodine solution in a dose of 10 drops 3 times a day for s hrs. Scans were made immediately and at 24-and 48-hr. intervals. The window of the pulseheight analyser was set to cover a range of gamma radiation between 320 and 490 Key.
The automatic contour-scanning device 4-6 consists essentially of twin matched detectors using scintillation crystals of thallium-activated sodium iodide measuring 1~I" X%.1 " Collimation openings are 1 ~ in diameter and ~ 89 in length. Each side of the head is scanned by both detectors sweeping from front to back and reversing in 9 concentric parasagittal arcs beginning along the midline. The detectors remain approximately perpendicular to the surface of the head. This scanning pattern, which is a departure from the usual rectilinear
